Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling
- PMID: 24839250
- PMCID: PMC4234699
- DOI: 10.1002/pon.3560
Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling
Abstract
Objective: Genetic testing for breast and ovarian cancer susceptibility is now part of routine clinical practice. Although rates of risk-reducing surgery following genetic testing have been increasing, little is known about attitudes toward risk-reducing surgery in women prior to genetic counseling and testing. This study examines correlates of patient intentions to undergo risk-reducing mastectomy (RRM) and risk-reducing oophorectomy (RRO).
Methods: Participants were 696 women, ages 21-85, who sought breast cancer gene 1 and 2 (BRCA1/2) genetic counseling and had at least a 10% risk of carrying a mutation. The sample included women who were affected with breast or ovarian cancer and unaffected women with a known familial BRCA1/2 mutation. Participants completed a precounseling telephone questionnaire.
Results: Prior to receiving genetic counseling, 23.3% of participants were considering RRM and 42.5% were considering RRO. Variables that were independently associated with RRM intentions were cancer-specific distress (OR = 1.14, 95% CI = 1.03-1.26), perceived risk of breast cancer (OR = 1.16, 95% CI = 1.05-1.28), education (OR = 1.76, 95% CI = 1.03-2.99), and age (OR = 0.96, 95% CI = 0.95-0.98). Predictors of RRO intentions were perceived risk for ovarian cancer (OR = 1.25, 95% CI = 1.14-1.37), perceived risk of carrying a BRCA1/2 mutation (OR = 1.74, 95% CI = 1.15-2.62), marital status (OR = 1.92, 95% CI = 1.34-2.76), and age (OR = 1.02, 95% CI = 1.00-1.03).
Conclusions: Because precounseling intentions predict subsequent risk-reducing surgery decisions, this study identified patient factors associated with surgical intentions. These factors reinforce the critical role for pretest genetic counseling in communicating accurate risk estimates and management options, and addressing psychosocial concerns, to facilitate informed decision making regarding RRM and RRO.
Keywords: BRCA1; BRCA2; cancer; genetic counseling; oncology; risk-reducing mastectomy; risk-reducing oophorectomy.
Copyright © 2014 John Wiley & Sons, Ltd.
Similar articles
-
Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.Transl Behav Med. 2020 May 20;10(2):337-346. doi: 10.1093/tbm/iby101. Transl Behav Med. 2020. PMID: 30418620 Free PMC article.
-
BRCA1/2 test results impact risk management attitudes, intentions, and uptake.Breast Cancer Res Treat. 2010 Dec;124(3):755-64. doi: 10.1007/s10549-010-0881-4. Epub 2010 Apr 10. Breast Cancer Res Treat. 2010. PMID: 20383578 Free PMC article.
-
Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.BMC Womens Health. 2010 Aug 5;10:24. doi: 10.1186/1472-6874-10-24. BMC Womens Health. 2010. PMID: 20687957 Free PMC article.
-
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2019 Aug 20;322(7):666-685. doi: 10.1001/jama.2019.8430. JAMA. 2019. PMID: 31429902
-
When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.J Genet Couns. 2017 Dec;26(6):1173-1178. doi: 10.1007/s10897-017-0136-1. Epub 2017 Aug 5. J Genet Couns. 2017. PMID: 28780755 Free PMC article. Review.
Cited by
-
Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.Curr Oncol Rep. 2019 Aug 15;21(10):85. doi: 10.1007/s11912-019-0836-9. Curr Oncol Rep. 2019. PMID: 31414239 Review.
-
Heightened perception of breast cancer risk in young women at risk of familial breast cancer.Fam Cancer. 2018 Jan;17(1):15-22. doi: 10.1007/s10689-017-0001-2. Fam Cancer. 2018. PMID: 28501958
-
What do people think about genetics? A systematic review.J Community Genet. 2019 Apr;10(2):171-187. doi: 10.1007/s12687-018-0394-0. Epub 2018 Nov 7. J Community Genet. 2019. PMID: 30406598 Free PMC article. Review.
-
Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study.Hered Cancer Clin Pract. 2022 Dec 19;20(1):38. doi: 10.1186/s13053-022-00244-y. Hered Cancer Clin Pract. 2022. PMID: 36536421 Free PMC article.
-
Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea.Cancer Res Treat. 2022 Apr;54(2):375-382. doi: 10.4143/crt.2021.449. Epub 2021 Aug 9. Cancer Res Treat. 2022. PMID: 34384016 Free PMC article.
References
-
- NCC Network [Accessed November 19, 2013];NCCN Clinical Practice Guidelines in Oncology. Genetic/familial high-risk assessment: breast and ovarian. [cited Version 3.2013. Available from: http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
-
- King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643–646. - PubMed
-
- Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol. 2005;23(30):7491–7496. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous